SLGL
SLGL
NASDAQ · Pharmaceuticals

Sol-Gel Technologies Ltd

$88.00
+1.10 (+1.27%)
As of Aug 8, 10:35 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target -85.9% upside
Low Target $7.31
Average Target $12.40
High Target $17.49
Current Price $88.00
Current
$88.00
Target
$12.40
$7.31 $12.40 avg $17.49
Scenario Analysis
Bear Case
$7.31
-91.7%
Low target
Base Case
$12.40
-85.9%
Avg target
Bull Case
$17.49
+-80.1%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$97.97
-10.2% from high
52-Week Low
$12.66
+595.1% from low
Target vs 52W High
$12.40
-87.3% vs high
Next Earnings Report
Aug 13, 2026
3d
until earnings
EPS Est: $-2.62
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%